FDA issued a Warning Letter to Synapse Biomedical Inc. on 6/20/2008 for a previous inspection.
483 Synapse Biomedical Oct 2020

483 Synapse Biomedical Oct 2020

Benjamin Dastoli FDA, Laureen Geniusz FDA$119.00 - Available Now

FDA investigators audited the Synapse Biomedical - Oberlin, OH, United States facility and issued inspectional observations (via FDA 483) on 07 Oct 2020.

Product details

  • Category: Medical Devices & Rad Health
  • Inspection end: 07 Oct 2020
  • Location: Oberlin, United States
  • FEI: 3005868392
Add To Cart